Global Duck Vaccines Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Duck Vaccines Market Research Report 2024
Vaccination is commonly used in commercial duck and increasingly in backyard birds to control disease.
According to Mr Accuracy reports new survey, global Duck Vaccines market is projected to reach US$ 551.9 million in 2029, increasing from US$ 375 million in 2022, with the CAGR of 5.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Duck Vaccines market research.
The duck vaccines market is witnessing steady growth due to the increasing demand for duck meat and the rising prevalence of avian diseases in duck populations. Duck vaccines play a vital role in preventing and controlling viral and bacterial diseases in ducks. The market is driven by factors such as the growth of the duck farming industry, rising consumer preference for duck products, and the need for effective disease management strategies. Advancements in vaccine development and technology, such as the availability of recombinant vaccines and improved vaccination techniques, are further fueling market growth. However, challenges such as the limited availability of specific duck vaccines for certain diseases and the high costs associated with vaccine procurement and administration may hinder market expansion. With the continuous focus on improving duck health, biosecurity measures, and sustainable duck farming practices, the duck vaccines market is expected to witness sustained growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Duck Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Boehringer Ingelheim
CEVA
CAHIC
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
Zoetis
Elanco
FATRO
CAVAC
Vaksindo
Segment by Type
Attenuated Live Vaccines
Killed Vaccines
Avian Influenza Vaccine
Newcastle Disease Vaccine
Other
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Duck Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Duck Vaccines market is projected to reach US$ 551.9 million in 2029, increasing from US$ 375 million in 2022, with the CAGR of 5.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Duck Vaccines market research.
The duck vaccines market is witnessing steady growth due to the increasing demand for duck meat and the rising prevalence of avian diseases in duck populations. Duck vaccines play a vital role in preventing and controlling viral and bacterial diseases in ducks. The market is driven by factors such as the growth of the duck farming industry, rising consumer preference for duck products, and the need for effective disease management strategies. Advancements in vaccine development and technology, such as the availability of recombinant vaccines and improved vaccination techniques, are further fueling market growth. However, challenges such as the limited availability of specific duck vaccines for certain diseases and the high costs associated with vaccine procurement and administration may hinder market expansion. With the continuous focus on improving duck health, biosecurity measures, and sustainable duck farming practices, the duck vaccines market is expected to witness sustained growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Duck Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Boehringer Ingelheim
CEVA
CAHIC
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
Zoetis
Elanco
FATRO
CAVAC
Vaksindo
Segment by Type
Attenuated Live Vaccines
Killed Vaccines
Segment by Application
Avian Influenza Vaccine
Newcastle Disease Vaccine
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Duck Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source